| Unique ID issued by UMIN | UMIN000054889 |
|---|---|
| Receipt number | R000062411 |
| Scientific Title | Efficacy and duration of robotic gait training for post-artificial joint surgery patients |
| Date of disclosure of the study information | 2024/07/05 |
| Last modified on | 2024/07/04 16:51:08 |
Efficacy and duration of robotic gait training for post-artificial joint surgery patients
Efficacy and duration of robotic gait training for post-artificial joint surgery patients
Efficacy and duration of robotic gait training for post-artificial joint surgery patients
Efficacy and duration of robotic gait training for post-artificial joint surgery patients
| Japan |
Patients with osteoarthritis, including those who have undergone total knee replacement
| Orthopedics | Rehabilitation medicine |
Others
NO
The primary objective of this study was to determine the effects of robot-assissted gait training (RAGT) on walking ability, physical function, and pain in a group of patients who underwent RAGT for 1 to 2 weeks postoperatively. The secondary objective was to evaluate the degree of effort and training intensity of RAGT.
Efficacy
Walking speed: Self-selected walking speed (SWS), and Maximum walking speed (MWS)
*Measurements were typically taken preoperatively, 2 weeks postoperatively, 4 weeks postoperatively, and 8 weeks postoperatively
Average step length at SWS and MWS
Cadence at SWS and MWS
Range of motion of knee extension (passive and active)
Range of motion of knee flexion (passive and active)
Maximum torque in knee extension and flexion
Maximum torque in knee flexion
Western Ontario and McMaster Universities osteoarthritis index (WOMAC) pain subscale (WOMAC-p) and physical function subscale (WOMAC-f)
*Measurements were typically taken preoperatively, 2 weeks postoperatively, 4 weeks postoperatively, and 8 weeks postoperatively
Observational
| 20 | years-old | <= |
| Not applicable |
Male and Female
Patients admitted to the hospital or outpatients who are able to practice walking
1) Those who are under 20 years of age
2) Those whose height is less than 140 cm.
3) Those with significant cognitive decline or higher brain dysfunction
4) Persons who use a pacemaker
5) Patients who have difficulty wearing the HWA-01.
6) Others who are judged by the attending physician to be unable to participate.
50
| 1st name | Hirotaka |
| Middle name | |
| Last name | Mutsuzaki |
Ibaraki Prefectural University of Health Sciences
Center for Medical Sciences
300-0394
4669-2 Ami, Inashiki-gun, Ibaraki
029-888-4000
mutsuzaki@ipu.ac.jp
| 1st name | Hirotaka |
| Middle name | |
| Last name | Mutsuzaki |
Ibaraki Prefectural University of Health Sciences
Center for Medical Sciences
300-0394
4669-2 Ami, Inashiki-gun, Ibaraki
029-888-4000
mutsuzaki@ipu.ac.jp
Ibaraki Prefectural University of Health Sciences
Ibaraki Prefectural University of Health Sciences
Other
Ethics Committee of the Ibaraki Prefectural University of Health Sciences
4669-2 Ami, Inashiki-gun, Ibaraki
029-888-4000
kyoumu@ipu.ac.jp
NO
| 2024 | Year | 07 | Month | 05 | Day |
Unpublished
51
Completed
| 2024 | Year | 06 | Month | 20 | Day |
| 2024 | Year | 06 | Month | 06 | Day |
| 2024 | Year | 06 | Month | 20 | Day |
| 2024 | Year | 06 | Month | 20 | Day |
#Study Design
Case-control study
#Subjects to be observed
Patients who were hospitalized and underwent total knee arthroplasty between May 2020 and May 2023, and who met the selection and exclusion criteria.
#Items to be measured
Patient background information such as age, gender, weight, and height.
Gait function, knee joint range of motion, knee function and pain, and knee joint muscle strength at preoperative, 2 weeks postoperative, 4 weeks postoperative, and 8 weeks postoperative periods (details of the evaluation items are described in a separate section).
| 2024 | Year | 07 | Month | 05 | Day |
| 2024 | Year | 07 | Month | 04 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062411